Centre hospitalier universitaire de Limoges

Where the EU money came from

Funding by EU programme. Amounts are Centre hospitalier universitaire de Limoges's own share of each project, not the project's full budget.

Projects

14 EU-funded projects, newest first. Each links to the official record.

• JA PCMAssociated partner

  Joint Action Personalised Cancer Medicine

  EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

  €29ktheir share
• ECOPOPPartner

  EARLY COLORECTAL CANCER: PATIENT-TARGETED AND ORGAN PRESERVING TREATMENT ECOPOP

  Horizon Europe · 2025–2029 · Project on CORDIS ↗

  €412ktheir share
• ORCHIDEEAssociated partner

  « ORCHIDEE » Project - Developing a New National Epidemiological Surveillance Hospital Network through Secondary Health Data Usage in Hospitals

  EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

  €152ktheir share
• EUnetCCC JAAssociated partner

  The European Comprehensive Cancer Centre Network

  EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

  €18ktheir share
• AISNPartner

  Integrating AI in Stroke Neurorehabilitation

  Horizon Europe · 2022–2027 · Project on CORDIS ↗

  €105ktheir share
• HORUSAssociated partner

  Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation

  Horizon Europe · 2022–2027 · Project on CORDIS ↗
• ECRAID-BasePartner

  European Clinical Research Alliance on Infectious Diseases

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗

  €2.0Mtheir share
• EU-JAMRAIAssociated partner

  European Joint Action on antimicrobial resistance and associated infections

  3rd Health Programme · 2017–2021 · Project on the EU portal ↗

  €37ktheir share
• SEPCELLPartner

  Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje

  Horizon 2020 · 2015–2022 · Project on CORDIS ↗

  €2.2Mtheir share
• COMBACTE-CAREPartner

  Combatting Bacterial Resistance in Europe - Carbapenem Resistance

  FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  €2.6Mtheir share
• COMBACTE-MAGNETPartner

  Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections

  FP7 (2007 to 2013) · 2015–2021 · Project on CORDIS ↗

  €33.9Mtheir share
• BIOMARGINPartner

  Biomarkers of renal graft injuries in kidney allograft recipients

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  €241ktheir share
• COMBACTE-NETPartner

  Combatting Bacterial Resistance in Europe

  FP7 (2007 to 2013) · 2013–2021 · Project on CORDIS ↗

  €49.0Mtheir share
• MITOTARGETPartner

  Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics

  FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

  €145ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 8 shared projects
• Assistance Publique Hopitaux de ParisFrance · 6 shared projects
• Servicio Madrileno de SaludSpain · 6 shared projects
• Servicio Andaluz de SaludSpain · 6 shared projects
• Katholieke Universiteit LeuvenBelgium · 5 shared projects
• Universitair Medisch Centrum UtrechtNetherlands · 5 shared projects
• Cliniques Universitaires Saint-Luc ASBLBelgium · 5 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 4 shared projects
• Universiteit AntwerpenBelgium · 4 shared projects
• Eberhard Karls Universitaet TuebingenGermany · 4 shared projects
• Universite de GeneveSwitzerland · 4 shared projects
• Charite - Universitaetsmedizin BerlinGermany · 4 shared projects
• Universitaetsklinikum Hamburg-EppendorfGermany · 4 shared projects
• Universitaet UlmGermany · 4 shared projects
• Universitaetsklinikum FreiburgGermany · 4 shared projects
• Klinikum der Universitaet zu KoelnGermany · 4 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• alzheimer
• amyotrophic lateral sclerosis
• antibiotic resistance
• antibiotics
• artificial intelligence
• bacteriology
• critical care medicine
• drug discovery
• epidemics prevention
• immunology
• infectious diseases
• lipids
• mass spectrometry
• mortality